Advisor Group Holdings, Inc. Rocket Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,413 shares of RCKT stock, worth $11,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,413

Previous 854 299.65%

Holding current value

$11,228

Previous $2,000 300.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$2.33 - $8.01 $5,962 - $20,497	2,559 Added 299.65%	3,413 $8,000
Q2 2025 Aug 13, 2025	SELL	$2.33 - $8.01 $6,477 - $22,267	-2,780 Reduced 76.5%	854 $2,000
Q1 2025 May 12, 2025	BUY	$6.67 - $12.72 $23,231 - $44,303	3,483 Added 2306.62%	3,634 $24,000
Q4 2024 Jun 06, 2025	SELL	$11.35 - $18.82 $32,619 - $54,088	-2,874 Reduced 79.09%	760 $9,000
Q4 2024 Feb 07, 2025	SELL	$11.35 - $18.82 $2,610 - $4,328	-230 Reduced 60.37%	151 $1,000
Q3 2024 Nov 13, 2024	SELL	$17.6 - $25.88 $246 - $362	-14 Reduced 3.54%	381 $7,000
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $2,871 - $3,714	139 Added 54.3%	395 $8,000
Q1 2024 May 10, 2024	SELL	$26.16 - $30.74 $59,540 - $69,964	-2,276 Reduced 89.89%	256 $6,000
Q4 2023 Feb 12, 2024	SELL	$16.78 - $31.94 $3,708 - $7,058	-221 Reduced 8.03%	2,532 $75,000
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $7,595 - $12,121	504 Added 22.41%	2,753 $56,000
Q2 2023 Aug 10, 2023	BUY	$16.59 - $23.6 $4,147 - $5,900	250 Added 12.51%	2,249 $44,000
Q1 2023 May 12, 2023	BUY	$15.79 - $22.6 $1,200 - $1,717	76 Added 3.95%	1,999 $34,000
Q4 2022 Feb 10, 2023	BUY	$15.5 - $22.76 $26,706 - $39,215	1,723 Added 861.5%	1,923 $37,000
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $556 - $828	-45 Reduced 18.37%	200 $3,000
Q2 2022 Aug 10, 2022	SELL	$7.96 - $16.64 $334 - $698	-42 Reduced 14.63%	245 $4,000
Q1 2022 May 04, 2022	BUY	$13.16 - $23.68 $144 - $260	11 Added 3.99%	287 $4,000
Q2 2021 Aug 02, 2021	SELL	$39.41 - $47.25 $3,862 - $4,630	-98 Reduced 26.2%	276 $12,000
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $6,197 - $9,425	143 Added 61.9%	374 $16,000
Q4 2020 Feb 10, 2021	BUY	$23.3 - $59.57 $4,660 - $11,914	200 Added 645.16%	231 $13,000
Q1 2020 May 18, 2020	BUY	$9.71 - $25.11 $301 - $778	31 New	31 $0

Others Institutions Holding RCKT

# of Institutions

218

Shares Held

98.2M

Call Options Held

608K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $249M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Rocket Pharmaceuticals, Inc. Transaction History